Home › Funds › Penn Capital Management Company, LLC › ANIP
Penn Capital Management Company, LLC position in ANIP
ANI PHARMACEUTICALS INC · Health Care
Penn Capital Management Company, LLC reported holding 213,246 shares of ANIP (ANI PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$15.5M, representing 1.15% of its reported portfolio and ranking #44 among its reported holdings. Penn Capital Management Company, LLC has disclosed ANIP holdings in 7 of the last 7 reported quarters, going back to Q1 2025.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Penn Capital Management Company, LLC's ANIP position evolved
Penn Capital Management Company, LLC first disclosed a stake in ANIP in Q1 2025 at 6,696 shares (US$448K). The position peaked in Q2 2026 at 207,362 shares, worth US$17.2M. Across 7 filings, Penn Capital Management Company, LLC increased the stake 5 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 213,246 shares valued at US$15.5M — an increase of 5,884 shares quarter over quarter.. Notable position changes include a 2059% increase in Q4 2025 (shares fell 3% over the following quarter), a 31% increase in Q1 2026 (shares rose 8% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2025 | 6.70K | $448.30K | New |
| Q2 2025 | 5.98K | $390.00K | Reduce |
| Q3 2025 | 6.36K | $582.94K | Add |
| Q4 2025 | 137.39K | $10.86M | Add |
| Q1 2026 | 179.72K | $13.83M | Add |
| Q2 2026 | 207.36K | $17.18M | Add |
| Q3 2026 | 213.25K | $15.52M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ANIP and 13F data
ANIP (ANI PHARMACEUTICALS INC) is a Health Care company. 41 other funds we track also report a position in ANIP — the largest reported positions include Soleus Capital Management, L.P. (US$71.8M), TANG CAPITAL MANAGEMENT LLC (US$58.6M), Empyrean Capital Partners, LP (US$29.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ANIP
- Soleus Capital Management, L.P. 867.76K sh · $71.83M · Q2 2026
- TANG CAPITAL MANAGEMENT LLC 707.50K sh · $58.57M · Q2 2026
- Empyrean Capital Partners, LP 23.00M sh · $29.75M · Q2 2026
- HBK INVESTMENTS L P 20.15M sh · $26.12M · Q2 2026
- Ikarian Capital, LLC 272.08K sh · $22.52M · Q2 2026
- Ranger Investment Management, L.P. 268.63K sh · $19.52M · Q3 2026
- Parkman Healthcare Partners LLC 202.91K sh · $16.80M · Q2 2026
- Boussard & Gavaudan Investment Management LLP 13.35K sh · $16.46M · Q1 2026
More on Penn Capital Management Company, LLC
FAQ
How long has Penn Capital Management Company, LLC held ANIP?
Penn Capital Management Company, LLC has disclosed ANIP holdings in 7 of the last 7 reported quarters, going back to Q1 2025.
What is Penn Capital Management Company, LLC's current position in ANIP?
As of Q3 2026, Penn Capital Management Company, LLC holds 213.25K shares of ANIP (ANI PHARMACEUTICALS INC), valued at $15.52M, representing 1.15% of its reported portfolio and ranking #44.
Has Penn Capital Management Company, LLC been buying or selling ANIP?
In the latest 13F filing (Q3 2026), Penn Capital Management Company, LLC increased its position in ANIP. The position peaked in Q2 2026 at 207.36K shares.
Which other funds hold ANIP?
Other major institutional holders of ANIP include Soleus Capital Management, L.P., TANG CAPITAL MANAGEMENT LLC, Empyrean Capital Partners, LP, among 41 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.